Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria
Magerl, M., Rother, M., Bieber, T., Biedermann, T., Brasch, J., Dominicus, R., Hunzelmann, N., Jakob, T., Mahler, V., Popp, G., Schäkel, K., Schlingensiepen, R., Schmitt, J., Siebenhaar, F., Simon, J.C., Staubach, P., Wedi, B., Weidner, C., Maurer, M.
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2013)
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2013)
Get full text
Journal Article
Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009
Schlingensiepen, Karl-Hermann, Schlingensiepen, Reimar, Steinbrecher, Andreas, Hau, Peter, Bogdahn, Ulrich, Fischer-Blass, Birgit, Jachimczak, Piotr
Published in Cytokine & growth factor reviews (01.02.2006)
Published in Cytokine & growth factor reviews (01.02.2006)
Get full text
Journal Article
Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: a word of caution
Maus, U, Rosseau, S, Mandrakas, N, Schlingensiepen, R, Maus, R, Muth, H, Grimminger, F, Seeger, W, Lohmeyer, J
Published in Antisense & nucleic acid drug development (01.02.1999)
Published in Antisense & nucleic acid drug development (01.02.1999)
Get more information
Journal Article
TGF-β2 suppression by the antisense oligonucleotide AP 12009 as treatment for pancreatic cancer: preclinical efficacy data
Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Jachimczak, P., Kielmanowicz, M., Schlingensiepen, R., Schlingensiepen, K.-H.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
TGF-β2 suppression by the antisense oligonucleotide AP 12009 as treatment for pancreatic cancer: preclinical efficacy data
Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Jachimczak, P., Kielmanowicz, M., Schlingensiepen, R., Schlingensiepen, K.-H.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Antisense oligomers for selective suppression of MCP-1 synthesis in human pulmonary endothelial cells
Maus, U A, Herold, S, Schlingensiepen, K H, Schlingensiepen, R, Dormayr, T, Rosseau, S, Maus, R, Seeger, W, Lohmeyer, J
Published in Antisense & nucleic acid drug development (01.06.2000)
Published in Antisense & nucleic acid drug development (01.06.2000)
Get more information
Journal Article
The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo
Schlingensiepen, K H, Wollnik, F, Kunst, M, Schlingensiepen, R, Herdegen, T, Brysch, W
Published in Cellular and molecular neurobiology (01.10.1994)
Published in Cellular and molecular neurobiology (01.10.1994)
Get more information
Journal Article
449 Treatment of pancreatic cancer by TGF-beta2 suppression mediated by the antisense oligonucleotide AP 12009: preclinical efficacy data
Stauder, G., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Kielmanocwicz, M., Jachimczak, P., Schlingensiepen, R., Schlingensiepen, K.
Published in European journal of cancer supplements (01.09.2004)
Published in European journal of cancer supplements (01.09.2004)
Get full text
Journal Article
820 TGF-beta1 suppression by the antisense oligonucleotide AP 11014 as treatment strategy for non-small cell lung cancer and colorectal cancer
Jachimczak, P., Schlingensiepen, K.-H., Schlingensiepen, R., Bischof, A., Graf, K., Hafner, M., Kielmanowicz, M., Szyrach, M., Stauder, G.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article
229 Suppression of TGF-beta2 in pancreatic cancer by the antisense oligonucleotide ap 12009: preclinical efficacy data as basis for clinical studies
Stauder, G., Jachimczak, P., Schlingensiepen, R., Goldbrunner, M., Graf, K., Kielmanowicz, M., Hafner, M., Szyrach, M., Bischof, A.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article
Developmental expression of the transcription factor zif268 in rat brain
Herms, Jochen, Zurmöhle, Uwe, Schlingensiepen, Reimar, Brysch, Wolfgang, Schlingensiepen, Karl-Hermann
Published in Neuroscience letters (03.01.1994)
Published in Neuroscience letters (03.01.1994)
Get full text
Journal Article
TGF-beta2 suppression by the antisense oligonucleotide AP 12009 as therapy for high-grade glioma: safety and efficacy results of phase I/II clinical studies
Hau, P, Bogdahn, U, Brawanski, A, Freudenstein, D, Goldbrunner, M, Grisold, W, Hundsberger, T, Koch, D, Kostron, H, Kunst, M, Mehdorn, M, Meixensberger, J, Pichler, J, Schackert, G, Schlaier, J, Schlingensiepen, R, Schmaus, S, Schneider, T, Spitznagel, L, Stauder, G, Stockhammer, G, Wassmann, H, Weller, M, Winking, M, Wurm, G, Schlingensiepen, KH
Published in Aktuelle Neurologie (07.09.2004)
Published in Aktuelle Neurologie (07.09.2004)
Get full text
Conference Proceeding
Changes of synapsin I messenger RNA expression during rat brain development
Zurmöhle, U M, Herms, J, Schlingensiepen, R, Schlingensiepen, K H, Brysch, W
Published in Experimental brain research (01.05.1994)
Published in Experimental brain research (01.05.1994)
Get more information
Journal Article
Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety
Schlingensiepen, Reimar, Goldbrunner, Michael, Szyrach, Mara N I, Stauder, Gerhard, Jachimczak, Piotr, Bogdahn, Ulrich, Schulmeyer, Frank, Hau, Peter, Schlingensiepen, Karl-Hermann
Published in Oligonucleotides (2005)
Published in Oligonucleotides (2005)
Get more information
Journal Article